Heartsciences Inc. 8-K Filing
Ticker: HSCSW · Form: 8-K · Filed: Dec 15, 2025 · CIK: 1468492
| Field | Detail |
|---|---|
| Company | Heartsciences Inc. (HSCSW) |
| Form Type | 8-K |
| Filed Date | Dec 15, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Heartsciences Inc. (ticker: HSCSW) to the SEC on Dec 15, 2025.
How long is this filing?
Heartsciences Inc.'s 8-K filing is 2 pages with approximately 536 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-15 16:17:13
Filing Documents
- hscs-20251215.htm (8-K) — 48KB
- hscs-ex99_1.htm (EX-99.1) — 20KB
- 0001193125-25-319234.txt ( ) — 211KB
- hscs-20251215.xsd (EX-101.SCH) — 45KB
- hscs-20251215_htm.xml (XML) — 6KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On December 15, 2025, HeartSciences Inc. (the "Company") issued a press release providing information regarding the Company's financial and operating results for the quarter ended October 31, 2025, and other business updates. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated by reference herein. The information contained in Item 2.02 of this Current Report and Exhibit 99.1 to this Current Report shall not be deemed to be "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filings made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1* Press Release dated October 31, 2025 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEARTSCIENCES INC. Date: December 15, 2025 By: /s/ Andrew Simpson Andrew Simpson President, Chief Executive Officer and Chairman of the Board of Directors